Abstract Vascular endothelial growth factor (VEGF) is associated with endothelial cell proliferation, migration and angiogenesis. Estrogen-related receptor γ (ERRγ) plays important regulatory roles in fatty acid oxidation, mitochondrial biogenesis and gluconeogenesis. Recently, ERRγ has been shown to be involved in angiogenesis; however, the mechanism of ERRγ-mediated angiogenesis is poorly understood. Here the results show that ERRγ activates VEGF gene transcription via two putative estrogen-related receptor binding elements (ERREs) mapped to the promoter region. Chromatin immunoprecipitation assays confirmed that ERRγ binds to the identified ERREs. Adenovirus-mediated overexpression of ERRγ increased the expression of VEGF gene and induced an increase in VEGF secretion in C2C12 myotubes. In contrast, the secretion of VEGF was significantly decreased in the presence of the ERRγ inverse agonist GSK5182. Furthermore, treatment of human umbilical vein endothelial cells (HUVECs) with the conditioned medium from ERRγ-overexpressing C2C12 myotubes significantly increased proliferation, migration and tube formation. These data indicate that VEGF functions as a downstream target gene of ERRγ and mediates the effects of ERRγ on endothelial cells proliferation, migration and angiogenesis. This physiological function of ERRγ might provide a novel target for treatment of ischemic diseases.
Introduction
VEGF is a potent endothelial cell mitogen known to play key roles in vasculogenesis, angiogenesis and early postnatal life 1 . Genomic deletion of the VEGF gene in mice results in embryonic lethality due to a poorly organized cardiovascular network 2 . Oxygen tension plays an important role in regulating the expression of VEGF and hypoxia-inducible factor-1 alpha is the key mediator of the hypoxic responses 3 . Estrogen receptors have a direct transcriptional effect on VEGF gene expression 4, 5 . Secretion of VEGF and other angiogenic factors results in neovascularization, thus VEGF provides an important target treatment for ischemic diseases in human.
Peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) is a multifunctional transcriptional coactivator that regulates oxidative and mitochondrial metabolism in many tissues including muscle. Some genes induced by hypoxia and ischemia are regulated by PGC-1α, such as the glucose transporter 6 . PGC-1α regulates gene expression through coactivation of many transcription factors including the estrogen receptor and the estrogen-related receptor 7 . PGC-1α expression levels are elevated in various tissues by a number of external stimuli: hypobaric hypoxia elevates PGC-1α expression in mouse cerebral subcortex 8 ; cold temperatures elevate PGC-1α in brown adipose tissue; fasting leads to elevated expression in the liver; and exercise and decreased ATP levels increase expression in skeletal muscle 9 . Estrogen-related receptors (ERRs) belong to the family of orphan nuclear hormone receptors including ERRα, ERRβ, and ERRγ 10 . ERRγ is most highly expressed in the heart, brain, kidney and skeletal muscle 11 . It seems that ERRγ is an orphan receptor that does not require agonist-dependent activation 12 . Deletion of the ERRγ gene in the mouse is perinatal lethal, and analysis of the phenotype of this mouse model indicates ERRγ is essential for the transition from glycolysis to fatty acid oxidation in cardiac muscle during early postnatal life 13 . Several genes are reported to be regulated by ERRγ, including SHP, PDK4, DAX-1 and MAO. Recent studies in ERRγ-null mice demonstrated that ERRγ regulates potassium homeostasis in the heart, kidney and stomach 14 . These studies focused on its role in energy metabolism. However, the ability of ERRγ to regulate endothelial cell proliferation, migration and angiogenesis remains unknown.
In this study, it is showed that levels of ERRγ and VEGF are elevated in the mouse soleus muscle in response to exercise. Adenovirus-mediated overexpression of ERRγ (Ad-ERRγ) stimulates VEGF expression and release in skeletal muscle cells. Moreover, we demonstrate that ERRγ regulates the expression of VEGF by binding to the two putative estrogen-related receptor binding elements (ERREs) in the VEGF promoter. Furthermore, conditioned medium from Ad-ERRγ-transfected C2C12 myotubes enhances primary human umbilical vein endothelial cell proliferation, migration and tube formation.
Materials and methods

Cell culture, adenovirus infection and reagents
HepG2 and C2C12 cells from ATCC were cultured in DMEM supplemented with 10% fetal bovine serum (FBS). Myotube differentiation was induced as previously reported 15 . After infection with the indicated adenoviruses, myotubes were washed with PBS for five times and cultured in fresh RPMI1640 supplemented with 1% FBS. After 48 h, the conditioned medium from four-day differentiated control or ERRγ over-expressing C2C12 myotubes was collected and stored at À70 1C before use. Primary mouse hepatocytes from the livers of 8-10-week old male C57BL/6 J mice were isolated and maintained as previously described 15 . Human monocytic cell line THP-1 cells were maintained in RPMI 1640 supplemented with 10% FBS. THP-1 cells were differentiated into adherent macrophages by treatment with 3 Â 10 À 8 -30 Â 10 À 8 M phorbol 12-myristate 13-acetate (PMA) for 72 h.
Cells were infected with the indicated adenoviruses at a multiplicity of infection sufficient to infect 495% of cells as determined by GFP fluorescence. The VEGF enzyme-linked immunoassay kit was from SciMall, Shanghai, China. GSK5182 was synthesized as previously described 16 . HUVECs were isolated from fresh umbilical cord as previously described 17 . Cells were cultured in RPMI1640 medium, containing 20% fetal bovine serum.
Exercise training
8 to 10-week-old male C57BL/6J mice were trained for a period of 8 days by running on a treadmill (12 m/min) for 2 h per day in the morning. Tissues were isolated immediately after the last bout of exercise training and total RNA was extracted using Trizol reagent for real-time PCR analysis.
Plasmid constructs
The mouse VEGF promoter (À 1508 to þ125 bp, referred to as -1508Luc) was amplified by PCR using mouse genomic DNA and cloned at HindIII and MluI sites of pGL3-basic reporter vector (Promega). To amplify different promoter regions, corresponding forward primers 5′-CTCAGAAGTCCAGCAGATC-3′ (-1508Luc), 5′-TTCCACAGGTCGTCTCACT-3′ (-916Luc), 5′-AAGTCTGC CGCACTCAAG-3′ (-608Luc), 5′-CCTCATACGTCCCTGCC-3′ (-355Luc) were used with the same reverse primer (5′-CTGGTGA-GTCCGCTGAATAG-3′). The site-direct mutagenesis was performed using the QuikChange kit (Stratagene, La Jolla, CA) according to the manufacturer's protocol. The wild-type oligonucleotide of ERRE1 and ERRE2 were 5′-ATGCTTCCGAGGTCAAACACGCAA-3′ and 5′-GAAAGCCAGGGGTCACTCTAGTTG-3′, whereas the mutant oligonucleotide of ERRE1 and ERRE2 were 5′-ATGCTTCC-GATTGTGAACACGCAA-3′ and 5′-GAAAGCCAGTTTGTGCTC-TAGTTG-3′. Clones were verified by sequencing. Adenovirus vectors expressing GFP, PGC-1α or ERRγ were prepared in our laboratory as previously described.
Transient transfection and luciferase assay
HepG2 cells were cultured in 24-well plates and transient transfection was performed as recommended by the manufacturer (Vigorous, Beijing, China). The DNA constructs harboring the 5′-deletion series of VEGF promoter or the mutant construct fused to luciferase reporter were cotransfected into HepG2 cells together with pcDNA3.1 (control) or ERRγ in the presence or absence of PGC-1α expression plasmids. 48 h after transfection, luciferase reporter assays were performed using the Dual Luciferase Reporter Assay System (Promega).
Chromatin immunoprecipitation assays
C2C12 myotubes were cultured and infected with adenoviruses expressing ERRγ-Flag, or GFP. After 48 h, cells were harvested in PBS and cross-linked by 1% formaldehyde, lysed and subjected to chromatin shearing by sonication. Samples were immunoprecipitated with anti-Flag (Sigma), or normal mouse control IgG (Sigma), followed by incubation with protein GSepharose. After chromatin immunoprecipitation, DNA was purified by phenol/chloroform extraction and used for PCR amplification. The primers were designed to amplify the region À770 to À 591 bp or À454 to À291 bp of the mouse VEGF promoter containing two putative ERRγ binding sites, ERRE1(-AGGTCA-): 5′-TCCTGATGACTGCAGATCAGAC-3′ (forward) and 5′-CTTGAGTGCGGCAGACTTTG-3′ (reverse); ERRE2 (-GGGTCA-): 5′-ACGCGTGTGTCAATGTGAGTGC-3′ (forward) and 5′-CCTTTCCCAGGAATATAGGAGA-3′ (reverse).
Real-time PCR
Total RNA was extracted by Trizol reagent and submitted for cDNA synthesis using random hexamers and a reverse transcription kit (Invitrogen, Carlsbad, CA). For gene expression analysis, real-time PCR was performed using a BioRad IQ5 instrument and SYBR super mix (Promega). GAPDH was used as an internal control.
Cellular proliferation/migration assay
HUVECs (2 Â 10 4 cells/well) were plated in 48-well plates. After 24 h, cells were washed five times with PBS and incubated with indicated conditioned medium for 48 h. Proliferation was measured using the thiazolyl blue tetrazolium bromide (MTT) colorimetric assay according to the manufacturer's recommendation (Sigma).
The cell migration assay was performed in a 24-well Boyden chamber. HUVECs were resuspended in RPMI1640 supplemented with bovine serum albumin (0.5%) and added to the upper chamber of the well, and the indicated conditioned medium was used as chemoattractant in the lower chamber. The cells were allowed to migrate for 12 h. Non-migratory cells were removed from the upper surface by scraping with a cotton swab. Migrated cells were fixed and stained with Hoechst 33342 dye. The number of cells was counted using lmaris software. Experiments were performed in triplicate.
Tube formation by HUVECs
A tube-formation assay was performed with a transwell system. Briefly, cells (5 Â 10 4 cells/200 μL) were seeded into the upper chamber; 24 h after seeding, the medium were replaced with fresh RPMI1640 supplemented with 10% bovine serum albumin and 50% conditioned medium. The cells were incubated at 37 1C for 96 h. Cells were stained and different microscopic fields (100 Â ) were photographed.
Statistical analysis
Data represent as means7S.D. of at least three independent experiments. Differences between groups were compared by student's t test and Po0.05 was considered statistically significant.
Results
Muscle VEGF and ERRγ expression is upregulated by exercise
To explore the physiological role of ERRγ in exercise-induced angiogenesis, we first studied the expression level of ERRγ in the mouse soleus muscle. Our data indicated that the ERRγ mRNA level was increased approximately 2-fold in the soleus muscle in response to exercise (Fig. 1A) . Interestingly, VEGF showed a similar expression pattern in the soleus muscle in response to exercise (Fig. 1B) .
As we observed a similar physiological upregulation of ERRγ and VEGF in response to exercise, we wondered whether ERRγ could affect the expression of the VEGF gene. To answer this question, adenovirus-mediated expression of ERRγ (Ad-ERRγ) was generated and the effect of ERRγ overexpression on VEGF mRNA expression was examined. As shown in Fig. 1C , exposure of C2C12 myotubes to Ad-ERRγ resulted in 2.8-fold increase in VEGF mRNA levels compared with Ad-GFP treatment. In addition, an upregulation of VEGF mRNA upon overexpression of ERRγ in primary mouse hepatocytes was detected (Fig. 1D) . Similar results were observed in HepG2 and THP-1 cells (Fig. 1E  and F) . Indeed, our microarray data also suggest VEGF as a potential target gene of PGC-1α in hepatocytes. Therefore, we investigated whether PGC-1α played a direct role in the regulation of VEGF gene expression. Adenovirus-mediated overexpression of PGC-1α resulted in a 1.8-fold up-regulation of VEGF mRNA in primary mouse hepatocytes (data not shown). These data indicated that ERRγ and PGC-1α functioned as upstream activators of VEGF gene expression in myotubes and hepatocytes.
Transactivation of VEGF promoter by ERRγ
To test whether ERRγ-mediated stimulation of VEGF gene expression occurred at the transcriptional level, a construct containing the mouse VEGF promoter was inserted into the reporter vector (pGL3-Basic) and transfected into HepG2 cells. Two putative ERR response elements (ERREs), located from À676 to À665 bp and À380 to À368 bp were found in VEGF promoter. First, a 1.5-kb-length ( À1508 to þ125 bp) fragment of the VEGF gene promoter region fused to the luciferase reporter vector (Luc-1508) was constructed. Cotransfection of the ERRγ expression vector with Luc-1508 resulted in a 3.8-fold activation of the reporter gene ( Fig. 2A) . In contrast, the transfection of the ERRα expression plasmid into HepG2 cells did not cause any activation of VEGF promoter (data not shown). Second, to map the cis-acting element conferring the ERRγ-induced stimulation of luciferase, a series of 5′ deletions of the VEGF promoter fused to the reporter vector were generated and the plasmids were transfected into HepG2 cells. As shown in Fig. 2A , ERRγ-mediated reporter gene activation was not significantly decreased upon the deletion of the À1508 to À608 bp region (still containing one putative ERRE) upstream of VEGF promoter transcription start site. However, when the reporter gene was further deleted to À355/þ125 bp (missing two putative ERREs), the activation by ERRγ was almost completely lost ( Fig. 2A) .
Next, we searched for the sequence motif in the VEGF promoter response to ERRγ and PGC-1α. HNF4 and ERRγ were reported to be coactivated by PGC-1α and several putative binding sites for these transcription factors were identified in the promoter of VEGF. To examine whether these transcription factors can activate the VEGF promoter together with PGC-1α, plasmids expressing these nuclear receptors with or without PGC-1α were co-transfected into HepG2 cells along with the reporter vector containing VEGF promoter fragments. HNF4 co-transfected with PGC-1α had no coactivation effect on luciferase activity as compared with cells transfected with PGC-1α alone (data not shown). As shown in Fig. 2A , cotransfection of PGC-1α and ERRγ led to a robust activation of the promoter. However, this activation was completely lost when the two ERREs in the VEGF promoter were deleted (Fig. 2A) .
To further confirm the involvement of the two ERREs in the response to ERRγ/PGC-1α in the VEGF promoter, the potential ERRγ binding sites were mutated in the Luc-1508 construct. When either putative ERRE in the VEGF promoter was mutated, the activation of the mutant construct (MUT1 or MUT2) by ERRγ or ERRγ/PGC-1α was modestly suppressed. However when both of the ERREs were mutated (MUT1þ2) activation was completely lost (Fig. 2B) . These results indicate that both ERREs are functional ERRγ cis-elements and that mutation of either ERRE alone does not block completely the ERRγ-mediated activation of VEGF gene expression.
ERRγ interacts with the ERREs in the VEGF promoter
To determine whether ERRγ bound to the putative ERREs in the VEGF promoter, chromatin immunoprecipitation (ChIP) assays were performed with chromatin isolated from C2C12 myotubes infected with adenovirus-mediated expression of ERRγ-Flag (Ad-ERRγ-Flag) or adenovirus-mediated expression of green fluorescent protein (Ad-GFP). Cross-linked chromatin fragments were precipitated with the indicated antibodies against Flag or the control IgG and used for amplification by PCR. The two ERREs in the VEGF promoter could be amplified from the precipitates obtained using the Flag antibody but not the control IgG sample (Fig. 2C) . In addition, a weak amplification of the same ERRE sequences in the VEGF promoter could be obtained via immunoprecipitation with anti-PGC-1α antibody (data not shown). These results demonstrate that ERRγ binds to the VEGF promoter in vivo.
Overexpression of ERRγ in cultured myotubes results in an increase of VEGF secretion into the medium
Thereafter, we studied whether ERRγ influenced VEGF secretion from C2C12 myotubes. C2C12 myoblasts were differentiated to Figure 3 Regulation of VEGF secretion by ERRγ in C2C12 cells. C2C12 myotubes were infected with adenovirus-mediated expression of GFP (Ad-GFP) or FLAG-tagged ERRγ (Ad-ERRγ); protein (A) and mRNA (B) expression of ERRγ was analyzed by Western Blotting and real-time PCR. (C) The VEGF concentration in the conditioned medium from differentiated control and ERRγ-overexpressing C2C12 myotubes (n ¼ 3) was measured by ELISA. (D) Cells were infected with Ad-GFP or Ad-ERRγ and the infection efficiency was determined by assaying GFP fluorescence. (E) C2C12 myotubes were treated with dimethyl sulfoxide (DMSO, control) or 1 μM GSK5182 for 72 h. The VEGF protein in the conditioned medium was measured by ELISA. *Po0.05 vs. GFP control. myotubes and exposed to Ad-ERRγ or Ad-GFP control. We observed an upregulation of ERRγ in the C2C12 myotubes infected with Ad-ERRγ compared with Ad-GFP (Fig. 3A and B) . We examined the VEGF protein levels in the conditioned medium. ELISA results showed that overexpression of ERRγ in C2C12 myotubes led to a 2-fold induction of secretion of VEGF protein into the cell culture medium as compared with the GFP control (Fig. 3C) . The infection efficiency was determined by assaying GFP fluorescence (Fig. 3D) . In contrast, treatment with the ERRγ inverse agonist GSK5182 decreased the VEGF secretion from the C2C12 myotubes into the medium (Fig. 3E). 3.5. Regulation of HUVEC proliferation, migration and tube formation by conditioned medium from Ad-ERRγ-treated myotubes
To test whether the conditioned medium from ERRγ-stimulated myotubes can promote endothelial cell proliferation, myotubes were infected with indicated adenovirus for 48 h and conditioned medium was collected as described in materials and methods. The presence of conditioned medium from ERRγ-treated myotubes significantly increased the proliferation of HUVECs compared with conditioned medium from GFP-treated myotubes (Fig. 4A) .
We investigated whether the enhanced release of VEGF induced by treatment with ERRγ in C2C12 myotubes resulted in a true increment in the angiogenic potential of the endothelial cells by testing the ability of the conditioned medium to stimulate the migration of HUVECs. A transwell migration assay showed that conditioned medium from myotubes treated with ERRγ caused greater endothelial cells migration compared with the GFP-treated control (Fig. 4B) .
The key aspect of angiogenesis is the formation of capillaries from endothelial cells. To determine if the conditioned medium from Ad-ERRγ-treated C2C12 myotubes can enhance HUVEC tube formation, HUVECs were cultured in a 24-well transwell chamber in RPMI1640, supplemented with 20% FBS. 24 h later, the medium was replaced with fresh RPMI1640 supplemented with 2% FBS and 50% conditioned medium. Indeed, treatment of HUVECs with conditioned medium from ERRγ-treated C2C12 myotubes increased tube formation at 72 h (Fig. 4C) .
These results indicate that VEGF protein expression and secretion is markedly induced by ERRγ expression, and the proliferation, migration and tube formation of HUVECs might be mediated by the VEGF in the conditioned medium released by myotubes infected with Ad-ERRγ. Figure 4 Conditioned medium from ERRγ-overexpressing C2C12 myotubes increased HUVEC proliferation, migration and tube formation. (A) HUVECs were treated as described in materials and methods, and relative cellular proliferation was measured by the MTT assay. (B) HUVECs were seeded in the upper chamber of a 24-well transwell chamber and the conditioned medium was used as a chemoattractant in the lower chamber. After 12 h, the nuclei of migrated cells were stained with Hoechst 33342 and the number of migrated cells was counted. (C) HUVECs were cultured as described in the materials and methods and tube formation by the cells was determined. The arrow indicates tube-like structure formation. *Po0.05 vs. control.
Discussion
ERRγ is constitutively active and it assumes an activated conformation in the absence of additional ligand 8 . The present study demonstrates that ERRγ alone is sufficient to stimulate VEGF expression at the transcriptional level. PGC-1α can also induce VEGF expression, and this effect might be partly mediated by ERRγ binding to the ERRE present in the promoter of VEGF. For more than fifteen years, intense investigations have indicated that VEGF plays important roles in the regulation of pathological angiogenesis and tumor growth 18 . However, VEGF also represents a key rate-limiting step in physiological angiogenesis 19 . VEGF gene expression is regulated by oxygen tension, oncogenes and several growth factors including TGF-α, KGF and PDGF 1 . In addition, exercise induces expression of VEGF in human skeletal muscle, which is consistent with our findings 20 . The transcriptional coactivator PGC-1α is expressed in tissues with high energy metabolism, such as BAT, heart, and skeletal muscle, and exercise stimulates PGC-1α expression in skeletal 21, 22 . ERRγ expression is also induced by exercise 23 . Current investigations on PGC-1α and ERRγ mainly focus on their ability to regulate energy metabolism. However, the roles they play in endothelial cell proliferation, migration and angiogenesis are largely unknown. Given the fact that ERRγ and VEGF are induced in the soleus muscle by exercise, we asked whether ERRγ can regulate VEGF expression and promote VEGF-mediated actions. To answer this question, we first cloned the VEGF promoter by PCR amplification of mouse genomic DNA, inserted the cloned DNA into the reporter vector pGL3-Basic. Overexpression of ERRγ or ERRγ/PGC-1α led to a 3.8-fold and nearly 6-fold induction of VEGF promoter activity, respectively. PGC-1α is known to coactivate ERRα, ERRγ and other transcriptional factors. Co-transfection of ERRα with PGC-1α also resulted in a 6-fold induction of VEGF promoter activity. However, the addition of ERRα alone had no effect on luciferase activity differentiating its actions from ERRγ. These data indicated that ERRγ, not ERRα, might be an essential mediator of PGC-1α-dependent and independent angiogenesis. Indeed, Rangwala et al. 23 reported that ERRγ can induce VEGF promoter activity, consistent with our data. However, they did not map the ERRγ binding sites in the VEGF promoter. ERRα and ERRγ have been reported to bind the conserved sequence AGGTCA 24 ; motif analysis of the VEGF promoter indicated two potential ERR binding sites located between À1508 and À355 bp. Our ChIP analysis demonstrated that ERRγ bound to the two ERREs in the VEGF promoter. Furthermore, treatment with the ERRγ inverse agonist GSK5182 decreased VEGF expression and secretion in C2C12 myotubes. Arany et al. 19 reported that silencing of ERRα expression abolished PGC-1α-induced VEGF expression, and they demonstrated that ERRα alone was sufficient to induce VEGF expression by 3-fold in primary skeletal muscle cells. However, our results indicated that transfected HepG2 cells with an ERRα expression vector had no effect on VEGF promoter activity (data not shown). These paradoxical results may be caused by different experimental conditions. Endothelial cell proliferation, migration and tube formation are especially important in angiogenesis. Upregulation of VEGF and improved angiogenesis is the major physiological response to exercise and hypoxia in the microenvironment 4, 25 . In this study we demonstrated that ERRγ and VEGF expression were increased in response to exercise. Based on these facts, we speculate that ERRγ may promote VEGF secretion and contribute to VEGF-induced endothelial cell proliferation, migration and angiogenesis. We found that overexpression of ERRγ resulted in increased VEGF secretion from C2C12 myotubes. This effect of ERRγ is PGC-1α-independent, but enhanced in presence of PGC-1α.
In conclusion, ERRγ can induce VEGF expression and secretion through binding to the two ERREs in the VEGF promoter, and this effect can be enhanced by PGC-1α co-expression. Small molecules that induce the expression of ERRγ might provide a novel treatment for ischemic diseases.
